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Abstract
The Mediator complex transmits activation signals from DNA bound transcription factors to the core transcription
machinery. In addition to its canonical role in transcriptional activation, recent studies have demonstrated that S. cerevisiae
Mediator can interact directly with nucleosomes, and their histone tails. Mutations in Mediator subunits have shown that
Mediator and certain chromatin structures mutually impact each other structurally and functionally in vivo. We have taken a
UV photo cross-linking approach to further delineate the molecular basis of Mediator chromatin interactions and help
determine whether the impact of certain Mediator mutants on chromatin is direct. Specifically, by using histone tail
peptides substituted with an amino acid analog that is a UV activatible crosslinker, we have identified specific subunits
within Mediator that participate in histone tail interactions. Using Mediator purified from mutant yeast strains we have
evaluated the impact of these subunits on histone tail binding. This analysis has identified the Med5 subunit of Mediator as
a target for histone tail interactions and suggests that the previously observed effect of med5 mutations on telomeric
heterochromatin and silencing is direct.
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Introduction
The eukaryotic Mediator complex is a transcriptional co-
activator for a wide variety of DNA-bound transcription factors
and also serves additional intricate roles in the regulation of
transcription [1]. The core of the S. cerevisiae complex is composed
of 21 polypeptides [2–4], which biochemical [5] and structural
studies [6] have assigned to structurally distinct modules of the
Mediator complex referred to as Tail, Middle and Head. In
addition, a separate subset of proteins termed the Cdk8 module is
variably associated with the core Mediator subunits [7,8].
Definitive genomic and proteomic analyses have revealed
orthologs for nearly all yeast Mediator subunits in higher
eukaryotes [9–11]. Parallel biochemical and genetic experiments
showed that certain subunits are critical for the activation of
specific sets of genes [2,12]. Transcriptional profiling in vivo
demonstrated that other Mediator subunits are essential for
transcription of virtually all genes in S. cerevisiae [13], suggesting
the complex was also a general transcription factor. A number of
genetic screens and experiments in S. cerevisiae have also established
an important role for some Mediator subunits in transcriptional
repression and silencing [14–20]. Our recent work on telomeric
silencing [21] and Mediator-chromatin [22] interactions suggests
that the mechanism used by Mediator to facilitate repression
involves an effect on chromatin.
Genome wide array studies have mapped Mediator occupancy
across entire chromosomes in S. cerevisiae [23] and S. pombe [24].
These studies revealed a uniformly composed core complex
upstream of active genes, but unexpectedly also upstream of
inactive genes and on the coding regions of some genes. Mediator
occupancy was also detected in transcriptionally silent regions of
yeast chromosomes, such as telomeres. Recent work has shown
that Mediator localizes to telomeres [21] independent of Rap1 and
the Sir proteins [25]. Mutations in several Mediator subunits,
which result in decreased Mediator occupancy at telomeres, also
lead to an increase in H4K16 acetylation, displacement of Sir
proteins, and desilencing of telomeric reporter genes [21,22,25]. In
vivo and in vitro studies suggest that Mediator does not bind
coincidentally with Sir proteins [21]. The occupancy of Mediator
near to, but not in, X elements suggest that Mediator may play a
critical role in formation of the boundary between heterochroma-
tin and euchromatin at telomeres. How Mediator targeting to
telomeres occurs and how it facilitates telomeric silencing are
important questions. Our studies of Mediator-chromatin interac-
tions have begun to yield insight into this question.
Consistent with the observation that purified Mediator and
mono-nucleosomes directly interact with each other [26], a broad
correlation between Mediator occupancy and nucleosome occu-
pancy in vivo has been observed [22]. In this same study, it was
additionally demonstrated that purified Mediator specifically binds
the N-terminal tails of histones H3 and H4. Mediator binding to
H4 tail peptides is decreased by the acetylation of lysines in this
peptide. Of the most commonly acetylated lysines, the acetylation
of H4K16 causes the most significant decrease in affinity of
Mediator for the N-terminal tail peptides. These findings were
validated by ChIP-chip analysis [22]. Although there is a broad
positive correlation between Mediator and nucleosome occupancy
in vivo, we specifically observed a strong negative correlation
between Mediator and nucleosomes acetylated at histone H4
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38416lysine 16. Since deacetylated H4 K16 chromatin is a hallmark of
silenced heterochromatin [27,28], these findings suggested that
direct interactions between Mediator and a specialized chromatin
structure at telomeres could lead to the targeting of Mediator to
heterochromatin and its effect on silencing at these loci.
An outstanding question from our recent studies was whether
the same Mediator subunits that impacted telomeric silencing,
such as Med5(Nut1)p, also impacted Mediator Histone tail
interactions [21]. In this study we have identified several Mediator
subunits that interact with histone tails, including Med5(Nut1)p.
We have observed that deletion of Med5(Nut1)p leads to a
decreased affinity of Mediator for the N-terminal tail of histone
H4, suggesting a direct connection between Mediator histone tail
binding and silencing.
Results
Two Bpa-containing H4 Tail Peptide Derivatives, H4
10 Bpa and H4 22 Bpa, Retain Wild Type Levels of
Mediator Binding
We adopted Bpa(benzoyl-phenylalanine)-mediated UV cross-
linking as a method to identify the Mediator subunits that are in
close proximity to the H4 tail peptide when it is bound to
Mediator. Bpa, a photoactivatable derivative of phenylalanine, can
be synthetically incorporated into peptides. Upon UV (,350 nm)
irradiation, the activated Bpa group tends to attack C–H bonds,
which are geometrically accessible, and form a covalent bond
between the Bpa-containing protein or peptide and its binding
partner [29]. Two Bpa-incorporated H4 tail probes, H4 10 Bpa
and H4 22 Bpa, were synthesized, in which Bpa was substituted
for a leucine at position 10 or appended to the C-terminus at
position 22 (Fig. 1-A). The concentration of H4 10 Bpa and H4
22 Bpa were able to be normalized to WT H4 peptide by SDS-
PAGE and Coomassie blue staining since the peptides had
virtually identical sequences (Fig. S1). To test if Bpa-incorporation
into the peptides compromised Mediator binding, the affinity of
Mediator for H4 10 Bpa, H422 Bpa and WT H4 was compared
in the histone tail binding experiment. Consistent with what was
observed previously [22], 2 mM of WT H4 peptide was sufficient
to deplete Mediator (,3 nM) complex in the input. H4 10 Bpa
and H4 22 Bpa peptides retain the ability to deplete Mediator at
2 mM concentration (Fig. 1-B). Even at a concentration of 1 mM,
all three peptides were still capable of pulling down Mediator,
indicating that H4 10 Bpa, H4 22 Bpa and WT H4 have
comparable affinity for Mediator.
H4 10 Bpa has Four Specific Cross-linking Targets within
Mediator
Our strategy to identify Mediator subunits that are on, or
proximate to, the H4 tail binding interface was to covalently
label these subunits with the Bpa-containing probes. Cross-
linked target proteins were detectable by streptavidin poly-HRP,
since the probes were biotinylated at their C-termini. Two
strong and two weak biotinylated bands on SDS-PAGE were
observed when the H4 10 Bpa and Mediator mixture was
exposed to UV irradiation (Fig. 2-A Lane 4). Using non-Bpa-
containing WT H4 tail peptide as the probe (Lane 1, 2),
omitting UV irradiation (Lane 5), or omitting Mediator in the
reaction (Lane 3) all resulted in the absence of these signals on
the blot (Fig. 2-A). These data demonstrate that the observed
pattern in Lane 4 specifically results from a Bpa-mediated
covalent cross-link between Mediator and H4 10 Bpa probe. By
analyzing H4 10 Bpa cross-linking products on a 10% SDS gel
(Fig. S2), we did not observe any other significant cross-linking
signals in the lower molecular weight range. The four bands
with high intensity and good reproducibility in the cross-linking
pattern were designated as BCT1 (H4 10 Bpa Cross-linking
Target 1), BCT2, BCT3 and BCT4 (Figure 2-A). The BCT1
and BCT3 signals were significantly and reproducibly stronger
than BCT2 and BCT4, suggesting that BCT1 and BCT3 may
be the primary targets of H4 tail binding. Distinct from H4
10 Bpa, H4 22 Bpa failed to generate detectable cross-linking
signals under the same conditions (Fig. 2-A, Lane 7). The H4
22 Bpa cross-linking samples analyzed by 10% SDS-PAGE also
showed no detectable signal in the lower molecular weight
range (data not shown). It is likely that position 22 is too distant
from the H4 binding site for the Bpa group to achieve efficient
cross-linking. Additional experiments were used to further
address the specificity of the H4 10 Bpa cross-linking result.
First, the UV exposure time and H4 10 Bpa concentration were
reduced. Fig. 2-B and 2-C show that shortening UV irradiation
or decreasing H4 10 Bpa concentration only led to general
weakening of the cross-linking signals, without significantly
changing the cross-linking pattern. Second, since the standard
concentration of H4 10 Bpa in cross-linking reactions was
4 mM, which was higher than the concentration typically used
for binding assays (1 mMo r2mM), we wanted to rule out non-
specific binding resulting from a higher peptide concentration.
As shown in Fig. 2-D, 4 mM H4 10 Bpa depleted Mediator in
the input, while H2B tail peptide (the non-specific binding
control [22]) was not able to pull down detectable amounts of
the complex, at identical or even double the concentration. The
interaction between Mediator complex and histone tail peptides
retains its specificity under the cross-linking conditions. Third,
H4 22 Bpa, which bound Mediator (Fig. 1-B), but did not cross-
link to the complex (Fig. 2-A Lane 7), was able to compete with
H4 10 Bpa in cross-linking experiments and attenuate the
BCT1-4 signals (Fig. 2-E). This attenuation was specific as
similar amounts of H2B peptide were not able to recapitulate
the effect (Fig. 2-F). We conclude that the H4 10 Bpa cross-
linking pattern relies on the specific interaction between
Mediator complex and H4 10 Bpa peptide.
Med5(Nut1)p, Med14(Rgr1)p, Med17(Srb4)p and Med1p
are H4 10 Bpa Cross-linking Targets
We used the approximate molecular weight of each BCT to
make a preliminary identification of the subunits of Mediator
that cross-linked to H4 10 Bpa. Referring to the silver staining
pattern of the WT Mediator complex, we assigned BCT2,
BCT3 and BCT4 as the H4 10 Bpa cross-linked form of
Med14(Rgr1)p, Med17(Srb4)p and Med1p respectively with
high confidence. The two largest subunits of Mediator,
Med15(Gal11)p and Med5(Nut1)p, have similar molecular
weights and co-migrate on SDS-PAGE. Therefore, BCT1 could
be the cross-linking products from either Med15(Gal11)p or
Med5(Nut1) or both. We designed an epitope tagging strategy
to confirm the preliminary assignments. The principle of this
strategy was that if a BCT signal was correctly assigned,
increasing the molecular weight of the target Mediator subunit
by tandem-Myc-tagging would alter the cross-linking pattern by
shifting the corresponding BCT signal to a higher molecular
weight. For this purpose, MED14(RGR1), MED17(SRB4) and
MED1 were each individually C’-MYC-tagged in the
MED18(SRB5)-3XFLAG background. These strains enabled the
affinity purification of each Mediator complex. We also MYC-
tagged MED5(NUT1) as an attempt to clarify the subunit(s)
represented by BCT1. The Myc-tagged Mediator complexes
were purified and compared with non-tagged WT Mediator
Mediator Subunits That Contact Histone H4
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B). Both methods validated the successful Myc-tagging and the
integrity of these Mediator complexes during purification. The
Myc-tagged Mediator complexes were found to bind to WT H4
tail (data not shown), and H4 10 Bpa (Fig. S3), with equal
affinity to non-Myc-tagged WT Mediator. The cross-linking
pattern of the Med17(Srb4)-10Myc Mediator complex (Fig. 3-C
Lane 3) shows that the original BCT3 band was absent and that
a new signal could be clearly observed between BCT1 and
BCT2. This result indicates BCT3 was correctly assigned and
represents the H4 10 Bpa labeled form of Med17(Srb4)p.
Similarly, a shift of BCT1 was found in the cross-linking
pattern of the Med5(Nut1)-13Myc Mediator complex (Fig. 3-C
Lane 5), indicating Med5(Nut1)p is the only cross-linking target
which generates BCT1 signal. It is unclear why the H4 10 Bpa
labeled form of Med5(Nut1)-13Myc protein appeared as a
doublet. In the cross-linking patterns of the Med14(Rgr1)-7Myc
and Med1-7Myc Mediator complexes (Fig. 3-C Lane 4 and
Lane 2), we observed the evident elimination of BCT2 and
BCT4 respectively. It was not readily apparent where these two
weaker BCT signals shifted. Given the distinct molecular weight
of Med14(Rgr1)p and Med1p, the chances are low that
assignment of BCT2 and BCT4 is incorrect. One interpretation
is that Med1p and Rgr1p may act as H4 10 Bpa weak transient
tethering sites, or just happen to be spatially proximal to the
direct binding sites and therefore get cross-linked by H4
10 Bpa. It is possible that this weak interaction or proximity
can be disrupted by Myc-tagging, thus resulting in Myc-tagged
Med1p or Med14(Rgr1)p no longer being H4 10 Bpa cross-
linking targets. The idea that Med1p and Med14(Rgr1)p have
weak H4 tail interactions is supported by our H4 binding assays
that show mutations in Med1p and Med14(Rgr1)p have little
direct impact on the affinity of Mediator for H4 tail peptide
(See Figs. 4 and 5). Another explanation for the inability to
detect the H4 10 Bpa cross-linked form of Med14(Rgr1)-7Mycp
could be its co-migration with the cross-linked form of WT
Med5(Nut1)p. Additional data that further support our assign-
ment of the BCT1-4 are discussed later in the results section. In
total, the evidence convincingly supports the identification
Med5(Nut1)p and Med17(Srb4)p as strong H4 10 Bpa cross-
linking targets, and Med14(Rgr1)p and Med1p as H4 10 Bpa
weak cross-linking targets.
The Dmed5(nut1) Mediator Complex has Compromised
Affinity for H4 Tail Peptide
To study the role of H4 10 Bpa cross-linking targets in H4
tail binding, we undertook the purification and characterization
of Mediator from strains with mutations in the cross-linking
target. We started by purifying the Dmed5(nut1) Mediator. As an
alternative to the previous conventional Dmed5(nut1) Mediator
purification [30], we constructed a Dmed5(nut1), MED18(SRB5)-
3FLAG yeast strain for affinity purification. We purified
Dmed5(nut1) Mediator and compared its composition with WT
Mediator complex by silver staining and immunoblotting (Fig. 4-
Figure 1. H4 10 Bpa and H4 22 Bpa retain wild type levels of Mediator binding. (A) Sequence alignment of WT H4, H4 10 Bpa and H4
22 Bpa peptide used in binding and cross-linking experiments. (B) Western blot analysis of histone tail binding experiment comparing Mediator
binding affinity of WT H4, H4 10 Bpa and H4 22 Bpa. WT Mediator complex (,3 nM) was mixed with each biotinylated peptide (2 mMo r1mM)
(Input). After incubation with streptavidin beads, Mediator not associated with peptide was in the supernatant and saved as the flow-through fraction
(F.T.). Peptide-bound Mediator complex was eluted by boiling the beads in SDS-PAGE loading dye (Elution). The indicated percent of each sample
was analyzed by a Western blot in which the specific amount of Mediator was quantified by the specified antibodies against subunits from different
structural modules.
doi:10.1371/journal.pone.0038416.g001
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absent in the mutant Mediator, while the structural integrity of
the remaining complex is intact. We also found that Med1p,
another H4 10 Bpa cross-linking target, is substoichiometric in
the purified Dmed5(nut1) Mediator, suggesting that Med5(Nut1)p
may affect the assembly or stability of Med1p in the complex.
This result also supports the suggested spatial proximity between
the two proteins within the complex [3]. Next, we assayed the
H4 tail binding affinity of the Dmed5(nut1) Mediator. Compared
with the WT Mediator complex, significantly less Dmed5(nut1)
Mediator was pulled-down by H4 tail peptide, and much of the
mutant complex remained in the flow-through fraction (Fig. 4-
C). This defect is unlikely to be a result of a sub-population of
‘‘inactive’’ Mediator. Equimolar amounts of purified wild type
and Dmed5(nut1) Mediator have equivalent binding affinity for
CTD (C-terminal domain of RNA polymerase II), a bona fide
binding partner of Mediator [31], in a GST-CTD pull-down
experiment (Fig. 4-F). Combined, the above results indicate that
the Dmed5(nut1) Mediator, relative to wild type, has a decreased
affinity specifically for H4 tail peptide.
Missing Med1p in Mediator Complex does not
Compromise H4 Tail Binding
From the above result, it is unclear if the impaired H4 tail
binding affinity in the Dmed5(nut1) Mediator is caused by the
absence of Med5(Nut1)p, substoichiometric amounts of Med1p,
or both. To clarify this question, first we purified the Dmed1
Mediator complex. The silver staining pattern (Fig. 4-A) and
immunoblotting analysis (Fig. 4-B) showed that other than the
absence of Med1, no Mediator subunits are detectably
substoichiometric in the Dmed1 Mediator. When characterized
in the H4 tail binding assay, Dmed1 Mediator and WT
Mediator were found to have comparable affinity for H4 tail
peptide (Fig. 4-D). A very mild decrease in the affinity of the
Dmed1 Mediator was sometimes observed, but was not
reproducible and could have resulted from small decreases in
the amount of Med5p. The result indicates that Med1p does
not impact the Mediator-H4 tail interaction, and that the
decreased H4 tail binding affinity of Dmed5(nut1) Mediator does
not result from the substoichiometric amounts of Med1p in the
mutant complex. To validate this second conclusion, we purified
Mediator from the Dmed5(nut1)/Dmed1 strain. Aside from
missing Med5(Nut1)p and Med1p, no significant compositional
change was detected in Dmed5(nut1)/Dmed1 Mediator (Fig. 4-A
and 4-B). The Dmed5(nut1)/Dmed1 Mediator did not show any
further decrease in H4 tail binding affinity when compared with
the Dmed5(nut1) Mediator (Fig. 4-E). In the experiment in Fig. 4-
E the concentration of both Mediator and peptide was
increased, compared to the experiment in Fig. 4-C, in order
to allow for the sensitivity to evaluate any further decreases in
affinity caused by the absence/mutation of subunits in addition
to Med5(Nut1)p. The absence of Med1p, in the context of a
Figure 2. H4 10 Bpa has four specific cross-linking targets within Mediator. (A) SDS-PAGE blot probed with streptavidin poly-HRP to detect
biotinylated peptide cross-linked to Mediator subunits. WT H4, H4 10 Bpa and H4 22 Bpa (4 mM) were incubated in the presence or absence of the
WT Mediator complex (,7.5 nM) and exposed to UV for 15 min when indicated. Cross-linking products were resolved on 6% SDS-polyacrylamide gel,
transferred to to PVDF, detected by streptavidin poly-HRP, and referred to as BCTs (H4 10 Bpa Cross-linking Targets). A weak band with relatively
poor reproducibility was asterisked. (B) SDS-PAGE blot probed with streptavidin poly-HRP to detect biotinylated H4 10 Bpa peptide cross-linked to
Mediator subunits after different UV exposure times. Identical mixtures, which contain 7.5 nM Mediator complex and 4 mM H4 10 Bpa, were exposed
to UV for 0, 5, 10 or 15 min. (C) SDS-PAGE blot probed with streptavidin poly-HRP to detect biotinylated H4 10 Bpa peptide cross-linked to Mediator
subunits in reactions with varient H4 10 Bpa concentration. WT Mediator complex (,7.5 nM) was incubated with 1 mM, 2 mMo r4mM H4 10 Bpa
peptide and exposed to UV irradiation for 15 min. (D) Western blot analysis of histone tail peptide binding experiment comparing Mediator binding
affinity for H4 10 Bpa and H2B tail peptide under the identical concentrations to the cross-linking reactions. WT Mediator complex (,3 nM) was
mixed with H4 10 Bpa (4 mM) or synthetic biotinylated histone H2B N’-tail peptide (4 mMo r8mM) as the inputs. The basic steps and layout of the
analysis were as described earlier (Fig. 1). (E) and (F) SDS-PAGE blot probed with streptavidin poly-HRP to detect biotinylated H4 10 Bpa peptide
cross-linked to Mediator subunits, after H4 22 Bpa (E) or H2B tail peptide (F) was added at the indicated concentration.
doi:10.1371/journal.pone.0038416.g002
Mediator Subunits That Contact Histone H4
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tail binding.
The C-terminus of Med14(Rgr1) does not Directly
Contribute to the H4 Tail Binding Affinity of Mediator
Med14(Rgr1)p, unlike Med1p and Med5(Nut1)p, is a H4
10 BPA cross-linking target encoded by an essential gene.
Therefore, we used a biochemically well-characterized C-
terminal truncation mutant, med14(rgr1)-D2 [32,33],to study
the role of Med14(Rgr1)p in Mediator and H4 tail interactions.
Flag affinity purification was used to isolate the med14(rgr1)-D2
Mediator and the composition was compared to wild type
Mediator by immunoblotting analysis (Fig. 5-A). Consistent with
previous studies, med14(rgr1)-D2 truncation leads to the complete
Figure 3. Med5(Nut1)p, Med14(Rgr1)p, Med17(Srb4)p and Med1p are H4 10 Bpa cross-linking targets. Silver staining (A) and
immunoblotting analysis (B) comparing the composition of affinity-purified MYC-tagged and non-MYC-tagged WT Mediator complexes after 10%
SDS-PAGE. (C) A comparison of the cross-linking patterns of MYC-tagged Mediator complexes with the WT pattern using an SDS-PAGE blot probed
with streptavidin poly-HRP to detect biotinylated H4 10 Bpa peptide cross-linked to Mediator subunits. Each indicated Mediator species (,7.5 nM)
was incubated with H4 10 Bpa (4 mM). A ‘Long Exposure’ of the 79 kD region on the SDS-PAGE blot probed with streptavidin poly-HRP is shown for a
better view of the weak BCT4 signal in each sample.
doi:10.1371/journal.pone.0038416.g003
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the presence of Med1p, which is a reported component of
med14(rgr1)-D2 Mediator purified by conventional methods
[32,33]. Since Med5(Nut1)p was absent from the med14(rgr1)-
D2 Mediator, we predicted the med14(rgr1)-D2 mutant complex
should have a decreased H4 tail binding affinity. The decrease
in affinity of the med14(rgr1)-D2 Mediator for H4 tail is
comparable to the Dmed5(nut1) mutant complex (Fig. 5-B). This
Figure 4. Med5(Nut1)p is important for Mediator-H4 interaction, while Med1p is not. Silver staining (A) and immunoblotting analysis (B)
comparing the composition of affinity-purified Dmed5(nut1), Dmed1, and Dmed5(nut1)/Dmed1 and WT Mediator complexes after 10% SDS-PAGE. The
amount of each complex in the individual lanes was normalized by adjusting the load such that an equal signal from the a-flag and a-Med7
antibodies was present. (C) Western blot analysis of histone tail binding experiment comparing the H4 tail binding affinity of WT and Dmed5(nut1)
Mediator complexes. An equal concentration (,3 nM) of either WT or Dmed5(nut1) Mediator complex was mixed with WT H4 peptide (1 mM) and
with H2B peptide (1 mM) as the inputs. The basic steps and layout of the analysis were as described earlier (Fig. 1). (D) Western blot analysis of histone
tail binding experiment comparing the H4 tail binding affinity between WT and Dmed1 Mediator complexes. An equal concentration (,3 nM) of WT
or Dmed1 Mediator complex was mixed with WT H4 peptide (1 mM) and with H2B peptide (1 mM) as the inputs. (E) Western blot analysis of histone
tail binding experiment comparing the H4 tail binding affinity of WT, Dmed5(nut1) and Dmed5(nut1)/Dmed1 Mediator complexes. An equal
concentration (,6 nM) of WT, Dmed5(nut1) or Dmed5(nut1)/Dmed1 Mediator complex was mixed with WT H4 peptide (1.4 mM) as the inputs. (F)
Western blot analysis of GST-CTD pull down experiment comparing the GST-CTD binding affinity for WT and Dmed5(nut1) Mediator complexes. An
equal concentration (,15 nM) of WT or Dmed5(nut1) Mediator complex (Input) was incubated with glutathione beads, which were pre-loaded with
equal amounts of GST-CTD or GST. After incubation, the supernatant was saved as Flow-though (F.T.). Bound protein was eluted from the beads by
boiling them in SDS-PAGE loading dye (Elution). An indicated percent of each fraction was analyzed by immunoblotting using the specified
antibodies against Mediator subunits from different structural modules.
doi:10.1371/journal.pone.0038416.g004
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Mediator (the C-terminal part of Med14(Rgr1)p, Med16(Sin4)p
Med15(Gal11)p, Med2p, Med3(Pgd1)p, and Med1p) do not
make any direct contribution to Mediator-H4 tail binding
beyond the absence of Med5(Nut1)p.
Non-crosslinked Mediator Subunits, Med16(Sin4)p and
Med9(Cse2)p, do not Directly Influence H4 Tail Binding
To determine whether other Mediator subunits implicated in
chromatin related effects, other than those identified as direct
cross-linking targets, could indirectly influence H4 binding we
tested Mediator purified from a Dmed16(sin4) strain and a
Dmed9(cse2) strain. Med16(Sin4)p mutations are accompanied by
gross alterations in chromatin structure in vivo, and lead to the de-
repression of a subset of genes, potentially by an epigenetic
mechanism [14,34,35]. Med9(Cse2)p, a middle module subunit,
has also been shown to be important for transcriptional repression
[17]. We purified the Dmed16(sin4) and Dmed9(cse2) Mediator
complexes using Flag-tagged strains. Med15(Gal11)p, Med2p,
Med3(Pgd1)p and Med5(Nut1)p have been shown to be lost from
the conventionally purified Dmed16(sin4) Mediator [30,36]. By
silver staining (Fig. 6-A) and immunoblotting analysis (Fig. 6-B),
we confirmed the complete dissociation of the tail module and the
integrity of the middle and head modules in purified Dmed16(sin4)
Mediator [30,36]. Consistent with the absence of Med5(Nut1)p in
the Dmed16(sin4) Mediator, we also noted substoichiometric
amounts of Med1p. Conventionally purified Dmed9(cse2) Mediator
has been shown to lack Med1p and have substoichiometric
amounts of Med4p [37]. Dmed9(cse2) Mediator complex purified
by affinity approach recapitulated the above compositional
characteristics, as shown by silver staining (Fig. 6-A) and
immunoblotting (Fig. 6-B). As shown in Fig. 6-C, the absence of
Med16(Sin4)p and other Tail module subunits does not result in
further compromised H4 tail binding affinity when compared with
the Dmed5(nut1) Mediator. Combined with the H4 tail binding
data of the rgr1(med14)-D2 Mediator (Fig. 5), this result further
reinforced the conclusion that no Mediator tail module subunits
influence H4 tail binding through non-Med5(Nut1)p dependent
mechanisms. Furthermore, purified Dmed9(cse2) Mediator bound
to H4 tail peptide as tight as WT mediator complex (Fig. 6-D),
indicating Med9(Cse2)p and Med4p do not play important roles in
H4 tail binding.
H4 10 Bpa Cross-linking Patterns of the Mutant Mediator
Complexes Further Define Mediator-H4 Tail Interactions
Using the H4 10 Bpa probe and the above-characterized
mutant Mediator complexes, we were able to generate the H4
10 Bpa cross-linking pattern for each mutant Mediator (Fig. 7).
Several conclusions can be derived from this data. First, the
results further confirm Med5(Nut1)p, Med14(Rgr1)p and Med1p
as H4 10 Bpa cross-linking targets. The Med5(Nut1)p cross-
linking signal (BCT1) was absent from the cross-linking patterns
of the Dmed5(nut1), Dmed5(nut1)/Dmed1, Dmed16(sin4) and
rgr1(Med14)-D2 Mediator complexes, none of which contained
detectable levels of Med5(Nut1)p. Similarly, the Med1p cross-
linking product (BCT4) was absent in the Dmed1, Dmed5(nut1)/
Dmed1, rgr1(Med14)-D2 and Dmed9(cse2) cross-linking patterns.
Additionally, the full length Med14(Rgr1)p cross-linking signal
(BCT2) was not present in the cross-linking pattern of the
rgr1(Med14)-D2 Mediator complex. Second, the weak cross-
linking signal with poor reproducibility, which is marked in
Fig. 2-A, S2 and Fig. 7, is likely to represent occasionally cross-
linked Med16(Sin4)p since this band was completely abolished
in the cross-linking patterns of the Dmed16(sin4) and
rgr1(Med14)-D2 Mediator complexes. Third, there is no readily
identified signal indicating that the truncated form of
Med14(Rgr1)p was cross-linked to H4 tail in the rgr1(Med14)-
D2 Mediator complex cross-linking pattern. The potential
overlap of the truncated protein signal with Med17(Srb4) as
well as split signal of the rgr1(Med14)-D2p in Western blots
(Fig. 5-A), however, make difficult to rule this out. This result
suggests that H4 10 Bpa cross-linking targets the C-terminal
part of Med14(Rgr1)p. Med17(Srb4)p produces the only cross-
linking signal in the rgr1(Med14)-D2 Mediator pattern. An
interaction between Med17(Srb4)p and the H4 tail is likely to
be responsible for the residual H4 tail binding affinity of this
mutant complex. Finally, we did not observe any interdepen-
dency among the cross-linking signals. Hence, even though
Figure 5. The C-terminus of Med14(Rgr1)p does not directly contribute to H4-Mediator interaction. (A) Immunoblotting analysis
comparing the composition of affinity-purified rgr1(Med14)-D2 and WT Mediator complexes after 10% SDS-PAGE. (B) Western blot analysis of histone
tail binding experiment comparing the H4 tail binding affinity of WT, Dmed5(nut1) and rgr1(Med14)-D2 Mediator complexes. An equal concentration
(,6 nM) of WT, Dmed5(nut1) or rgr1(Med14)-D2 Mediator complex was mixed with WT H4 peptide (1.4 mM) as the inputs. The basic steps and layout
of the analysis were as described earlier (Fig. 1).
doi:10.1371/journal.pone.0038416.g005
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the H4 tail cross-linking almost certainly results from a weak
interaction with these subunits rather than their proximity to
the tighter interaction with Med5(Nut1)p.
Discussion
Our earlier work showed that Med5p(Nut1)p was required for
association of Mediator with the specialized chromatin structure at
yeast telomeres and the maintenance of silenced heterochromatin
in vivo [21]. Another branch of our work showed that Mediator can
interact with nucleosomes through the histone tails and that a
modification associated with silenced heterochromatin, H4
K16deAc, was important for this interaction [22]. It was an open
question whether the effect of Med5(Nut1)p on silenced hetero-
chromatin resulted from a direct effect on histone tail interactions.
In this study we have taken an unbiased approach to identifying
subunits within Mediator that interact directly with histone H4 N-
terminal tail. Our analysis identified Med5(Nut1)p and, by process
of elimination, Med17(Srb4)p as the sites on Mediator that provide
the primary affinity for H4 tail. The identification of Med5(Nut1)p
as a subunit that contributes to the affinity of Mediator for H4
further elucidates the previously observed effect of Med5(Nut1)p
on telomeric silencing. This result supports the idea that the
observed effects of med5(nut1) deletion on telomeric silencing in
vivo directly result from the absence of a Med5(Nut1)p-H4 tail
interaction. A second report on S. cerevisiae Mediator concluded
that mutations in several tail module subunits, but not Med5(-
Nut1)p, lead to the loss of telomeric silencing [25]. Although the
origin of the different results is still unclear, it may be related to the
different locus of the URA3 marker gene inserted in telomere
VIIL used in the above study that lacks the subtelomeric X and Y
elements [25].
Med17(Srb4)p is encoded by an essential gene and is considered
a key component of the structural core of Mediator [38–40].
Hence, it will be difficult to identify a potential contribution of the
H4 interaction with Med17(Srb4)p to telomeric silencing and
chromatin interactions in vivo until a specific binding interface is
identified that can be subject to point mutations or small deletions.
However, both the strong cross-linking signal, and experiments
Figure 6. Med16(Sin4)p and Med9(Cse2)p do not directly influence H4 tail binding. Silver staining (A) and immunoblotting analysis (B)
comparing the composition of affinity-purified Dmed16(sin4), Dmed9(cse2) and WT Mediator complexes after 10% SDS-PAGE. (C) Western blot analysis
of histone tail binding experiment comparing the H4 tail binding affinity of WT, Dmed5(nut1), and Dmed16(sin4) Mediator complexes. An equal
concentration (,4.7 nM) of WT, Dmed5(nut1),o rDmed16(sin4) Mediator complex was mixed with WT H4 peptide (1.4 mM) as the inputs. The basic
steps and layout of the analysis were as described earlier (Fig. 1). (D) Western analysis of histone tail binding experiment comparing the H4 tail
binding affinity of WT and Dmed9(cse2) Mediator complexes. An equal concentration (,3 nM) of WT or Dmed9(cse2) Mediator complex was mixed
with WT H4 peptide (1 mM) as the inputs.
doi:10.1371/journal.pone.0038416.g006
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module, purified under mildly denaturing conditions, binds H4 tail
with equal affinity to the Dmed5(nut1) Mediator (data not shown)
support the idea that Med17(Srb4)p is the second important H4
tail binding site in Mediator.
The next step in this line of inquiry will be to determine specific
domains, and even amino acids, within Med5(Nut1)p and
Med17(Srb4)p that are required for histone tail binding. Both
Med5(Nut1)p and Med17(Srb4)p are relatively large proteins and
have many potential sites for interaction with the histone tails. It
has previously been noted that residues 1–243 of Med5(Nut1)p
contain all four motifs characteristic of the GCN5-related N-
acetyltransferase (GNAT) superfamily, with similar spacings of the
motifs to those in other family members [26]. Med5(Nut1)p has a
weak histone acetyltransferase activity [26] and it is possible that
this motif now serves to bind H4 tail peptide. Structural studies of
GNAT superfamily member tGCN5 have shown that this motif
can help serve as a binding site for both histone H3 and histone
H4 N-terminal tails [41]. The identification of both Med5(Nut1)p
and Med17(Srb4)p as H4 binding partners suggests that perhaps
they might share a common motif used in binding. Although
Med17(Srb4)p is not a GNAT superfamily member, a direct
pairwise alignment of Med5(Nut1)p and Med17(Srb4)p searching
for local similarities (EMBOSS Matcher, EMBL-EBI) between the
two proteins revealed an ,40 amino acid stretch that has high
similarity between the two (Med5(Nut1)p a.a. 976–1016,
Med17(Srb4)p a.a. 145–186). Intriguingly this stretch has several
highly conserved aspartic acids and glutamic acids that might be
used to interact with a highly positively charged substrate, such as
a histone tail. This region, in Med5(Nut1)p, is not part of the
GNAT motifs and is unstructured in the crystal structure of
Med17(Srb4)p within the Mediator head module [40]. Coupling
mass spectrometry to our photo cross-linking approach and/or
systematic deletion of candidate regions in Med5(Nut1)p and
Med17(Srb4)p for H4 tail binding will be necessary to design
mutations that will allow us to more precisely test the effect of
these interactions in vivo.
Materials and Methods
Yeast Strains Construction
Med18(Srb5)p Flag-tagged strains with MYC-tagged Mediator
subunits (yZL1, yZL2, yZL3 and yZL4) were constructed by
individually targeting each gene in SHY349 [42] with the
corresponding PCR product generated from pFA6a-13myc-
His3MX6 [43]. To generate yeast strains for purifying mutant
Mediator complexes, MED18(SRB5)-3FLAG-NAT
R cassette, which
was amplified from yLM40 [44], was used to tag MED18(SRB5)
in the Dmed1 (strain #15489), Dmed9(cse2) (strain #15385) and
Dmed5(nut1) (strain #14518) strain from the
Saccharomyces Genome Deletion Project Libarary [45] to create
yLM79, yZL15 and yLM74 respectively. This cassette was also
used for the same purpose in DY2694 (rgr1-D2(med14)::LEU2) and
DY1876 (Dmed16(sin4)::TRP1) to generate yZL14 and yLM61
respectively. The MED1 ORF in yLM74 was deleted by the HIS3
marker amplified from pFA6a-His3MX6 [44] to generate yZL13.
The correct integration of each targeting DNA fragment was
confirmed by PCR and the success of the epitope tagging steps
were further verified by immunoblotting analysis. The complete
genotypes of all strains used in this study are listed in Table S1.
Affinity Purification of Mediator Complex
In addition to individual genetic modifications, all the yeast
strains used for Mediator complex purification in this study had a
triple FLAG tag at the C-terminus of MED18(SRB5) gene.
Affinity purification of each Mediator complex was performed as
previously described [44] with the following modifications. After
the salt concentration adjustment, crude cell lysate was first
applied on Bio-Rex 70 resin and Mediator eluted as previously
described [46]. Mediator containing Bio-Rex fractions eluted at
650 mM KOAc were added to anti-FLAG M2 agarose (Sigma).
Mediator complex products, which were eluted by 3XFlag
peptide, were further purified by size exclusion chromatography
(Superose 6 10/300 GL GE) in 25 mM HEPES KOH (pH 7.6),
5% glycerol, 0.01% NP-40, 300 mM KOAc. Fractions containing
intact Mediator were pooled and re-concentrated by anti-FLAG
agarose.
Histone Tail Peptide Binding Experiments
Histone tail binding experiments were performed as previously
described [22], except that the total reaction volume was reduced
to 50 ml. After incubation with streptavidin beads, the supernatant
was collected as flow-through fraction and TCA precipitated for
SDS-PAGE analysis. The input peptide concentration was varied
as described in the figure captions.
Figure 7. H4 10 Bpa cross-linking patterns of the mutant Mediator complexes. SDS-PAGE blot probed with streptavidin poly-HRP to detect
and compare the pattern of biotinylated peptide cross-linked to Mediator subunits in WT Mediator and the mutant Mediator complexes. Equimolar
amounts (,7.5 nM) of each indicated Mediator complex were incubated with H4 10 Bpa (4 mM) and exposed to UV for 15 min. Asterisk refers to the
same weak signal as in Fig. 2-A.
doi:10.1371/journal.pone.0038416.g007
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The H4 10 BPA peptide (SGRGKGGKG(BPA)GKG-
GAKRHKICGGK-biotin) and the H4 22 BPA
(SGRGKGGKGLGKGGAKRHKI(BPA)GGK-biotin) peptide
were synthesized at the Tufts University Core Facility. UV
cross-linking was conducted in 20 ml F300 buffer [25 mM HEPES
KOH (pH 7.6), 10% glycerol, 0.01% NP-40, 300 mM KOAc]
containing 4 mM H4 10 BPA (or other H4 tail peptide) and
7.5 nM purified Mediator. If a competitor peptide was present in
the experiment, it was added at this stage. The mixture was
incubated for 4 h and then exposed to 5 UV tubes (8-watt each,
365 nm) at a distance of 10 cm. Irradiation time was 15 min if not
otherwise specified. Cross-linking products were resolved by SDS-
PAGE and blotted by Streptavidin Poly-HRP (Thermo), which
was 1:15,000 diluted in TBST+2.5%BSA.
GST-CTD Pull-down Experiments
10 mg purified GST-CTD [31] or GST was bound to 5 mlo f
Glutathione MagBeads (Genscript). Unbound proteins were
removed by washing the beads in F300 buffer containing
0.5 mM DTT. 10 ml of wild-type or Dmed5(nut1) Mediator
(,15 nM) was added to the beads and incubated for 2 h. The
supernatant after incubation was saved as the flow-through
fraction representing the unbound Mediator. Bound Mediator
complex was eluted by boiling the beads in SDS-PAGE loading
dye.
Antibodies
All Western blots were developed using a AP(alkaline phospha-
tase)-conjugated secondary antibody and ECF (GE Healthcare)
reagent. The antibodies used for detecting invidual Mediator
subunits were as previously described [44].
Supporting Information
Figure S1 Normalization of peptide concentration. To
normalize the amounts of peptide added to binding and cross-
linking reactions, WT H4, H4 10 Bpa and H4 22 Bpa synthetic
peptide were diluted in SDS-PAGE loading dye and resolved by
Tricine-SDS-PAGE. Concentration of the peptides was calibrated
by Coomassie blue staining signals.
(TIF)
Figure S2 H4 10 Bpa cross-linking pattern resolved by
10% SDS-PAGE. SDS-PAGE blot probed with streptavidin
poly-HRP to detect biotinylated peptide cross-linked to Mediator
subunits resolved on 10% SDS-polyacrylamide. The high
molecular weight signals are labelled as previously described
(Fig. 2-A).
(TIF)
Figure S3 Myc-tagging does not interfere with the
binding between Mediator complex and H4 10 Bpa
peptide. Western blot analysis of a histone tail binding
experiment in which each indicated Mediator species (,3 nM)
was mixed with H4 10 Bpa (4 mM) as the input. The basic steps
and layout of the analysis were as described earlier (Fig. 1).
(TIF)
Table S1 Yeast strains used in this study.
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